Pfizer to share technology for COVID-19 antiviral drug, Paxlovid
Positive news for pharma sector, 19 Indian companies tie up with Medicines Patent Pool to manufacture Pfizer's COVID-19 antiviral drug, Paxlovid.
Pharma giant Pfizer might not have shared their technology behind its popular mRNA COVID-19 vaccine but it has opened the doors to share the technology for the COVID-19 antiviral drug, Paxlovid.
Pfizer, in November of last year, entered into a voluntary licensing agreement with Medicines Patent Pool (MPP) to share the technology for the drug.
Also Read:
MPP is a United Nations-backed Public Health Organisation founded in 2010. Its objective is to increase access, development of life-saving drugs such as HIV, TB, and Hepatitis C in low-to-middle income countries. When it comes to COVID-19, MPP has given a license to 27 companies to produce Molnupiravir, which is Merck’s COVID-19 antiviral drug in over 100 countries.
Watch the video for more details.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Gonda Lok Sabha election: BJP's Kirti Vardhan Singh takes on Beni Prasad Verma's granddaughter Shreya
May 19, 2024 10:19 PM
Faizabad Lok Sabha election: Can Ayodhya Ram Temple strengthen BJP's stronghold here?
May 19, 2024 10:16 PM
Amethi Lok Sabha election: Can BJP's Smriti Irani retain the Congress bastion she won in 2019?
May 19, 2024 10:12 PM
Rae Bareli Lok Sabha Election: Can Rahul hold on to this Gandhi family bastion?
May 19, 2024 10:09 PM